Additive inhibitory effects of treatment with an LHRH agonist and an antiandrogen on androgen-dependent issues in the rat

Molecular and Cellular Endocrinology

Volumn 21, Issue 1, 1981, Pages 37-41

  Séguin, Carl ^b   Cusan, Lionel ^b   Belanger, Alain ^b   Kelly, Paul A ^b   Labrie, Fernand ^b   Raynaud, Jean Pierre ^a  

^a SANOFI   (France)

^b NONE

Author keywords

antiandrogens; LHRH agonist; prostate; seminal vesicles

Indexed keywords

ANDROGEN; BUSERELIN; CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN; GONADORELIN DERIVATIVE; LUTEINIZING HORMONE; NILUTAMIDE; RADIOISOTOPE; TESTOSTERONE;

ANIMAL EXPERIMENT; BLOOD AND HEMOPOIETIC SYSTEM; DRUG MIXTURE; DRUG POTENTIATION; ENDOCRINE SYSTEM; MALE GENITAL SYSTEM; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; RADIOIMMUNOASSAY; RAT; SEMINAL VESICLE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BUSERELIN; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; IMIDAZOLES; IMIDAZOLIDINES; LUTEINIZING HORMONE; MALE; ORGAN SIZE; PROSTATE; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, LH; SEMINAL VESICLES; TESTOSTERONE;

EID: 0019370226     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/0303-7207(81)90028-9     Document Type: Article

References (16)

1. Extension of Multiple Range Tests to Group Means with Unequal Numbers of Replications
2. Endocrine Approach to Male Contraception
3. J. Reprod. Fertil.